Developing game changing treatments and cell therapies for severe diseases

We develop and commercialize innovative treatments for patients with severe and life-threatening conditions. Our drug canditates have the potential to improve outcomes in the treatment of neurological and ophthalmic disease and for ground-breaking regenerative cell therapies. They give hope for patients lacking satisfactory alternatives.


Read more

“We are very excited about the clinical potential for ILB, which may prove to be a game changing treatment for many devastating diseases.”
Professor Ann LoganScientific Director, Neuregenix Ltd.

News


All News

Events


All Events

Science & pipeline

ILB – Neurology

ILB has the potential to treat neurodegenerative diseases for good

IBSOLVMIR – Cell therapy

IBSOLVMIR can improve the effects of cell therapy